Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             40 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A new approach to refractory gastrointestinal stromal tumours with diverse acquired mutations Nishida, Toshirou

21 7 p. 864-865
artikel
2 A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic Tiu, Crescens

21 7 p. 889-891
artikel
3 2020 ASCO Virtual Annual Meeting Collingridge, David

21 7 p. 885-886
artikel
4 Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial Heinrich, Michael C

21 7 p. 935-946
artikel
5 Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial Konstantinopoulos, Panagiotis A

21 7 p. 957-968
artikel
6 Cancer and the microbiome Gunjur, Ashray

21 7 p. 888
artikel
7 Cancer registration in China and its role in cancer prevention and control Wei, Wenqiang

21 7 p. e342-e349
artikel
8 Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study Tian, Jianbo

21 7 p. 893-903
artikel
9 Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study Yang, Kunyu

21 7 p. 904-913
artikel
10 Correction to Lancet Oncol 2020; 21: 271–82
21 7 p. e341
artikel
11 Correction to Lancet Oncol 2020; 21: 851–60
21 7 p. e341
artikel
12 Correction to Lancet Oncol 2020; 21: 923–34
21 7 p. e341
artikel
13 Correction to Lancet Oncol 2020; 21: 261–70
21 7 p. e341
artikel
14 Correction to Lancet Oncol 2020; 21: 808–20
21 7 p. e341
artikel
15 COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study Garassino, Marina Chiara

21 7 p. 914-922
artikel
16 Developing anti-CD19 antibody-based combinations in lymphoma Kuruvilla, John

21 7 p. 870-872
artikel
17 Digital tools for sharing genetic information with family members Phillips, Amicia

21 7 p. 891-892
artikel
18 ESGO–SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers Sessa, Cristiana

21 7 p. e360-e368
artikel
19 Has dose-dense chemotherapy met an ICONic end? Hinchcliff, Emily M

21 7 p. 869-870
artikel
20 Is downstaging a reliable strategy for expanding criteria for liver transplantation in hepatocellular carcinoma? Ferrer-Fàbrega, Joana

21 7 p. 867-869
artikel
21 Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial Mazzaferro, Vincenzo

21 7 p. 947-956
artikel
22 Lockdown poses new challenges for cancer care in India Sharma, Dinesh C

21 7 p. 884
artikel
23 Moving gastrointestinal stromal tumours towards truly personalised precision therapy Nguyen, Vi

21 7 p. 865-867
artikel
24 Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial Hui, David

21 7 p. 989-998
artikel
25 New advances in prostate cancer screening and monitoring Gourd, Elizabeth

21 7 p. 887
artikel
26 New approaches to cancer care in a COVID-19 world Butler, John

21 7 p. e339-e340
artikel
27 Opportunities to improve cancer control and progress towards universal health coverage in Commonwealth nations Ilbawi, André

21 7 p. 876-879
artikel
28 Optimal goal of management of delirium in end-of-life cancer care Akechi, Tatsuo

21 7 p. 872-873
artikel
29 Poor clinical outcomes for patients with cancer during the COVID-19 pandemic Tang, Liang V

21 7 p. 862-864
artikel
30 Proton beam or photon beam radiotherapy in the treatment of non-small-cell lung cancer Ramella, Sara

21 7 p. 873-875
artikel
31 Racism, discrimination, and the practice of oncology The Lancet Oncology,

21 7 p. 861
artikel
32 Radiation-induced angiosarcoma in a patient with breast cancer Malekpour, Mahdi

21 7 p. e369
artikel
33 Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus Mehanna, Hisham

21 7 p. e350-e359
artikel
34 Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial Blay, Jean-Yves

21 7 p. 923-934
artikel
35 Screening of gastrointestinal cancers during COVID-19: a new emergency Maida, Marcello

21 7 p. e338
artikel
36 Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study Salles, Gilles

21 7 p. 978-988
artikel
37 The Commonwealth: an anachronism or a relevant organisation for the future? Collingridge, David

21 7 p. 875-876
artikel
38 The role of faith organisations in cancer control and patient care Newcome, James

21 7 p. 882-883
artikel
39 The role of the Commonwealth in the wider cancer control agenda Lodge, Mark

21 7 p. 879-881
artikel
40 Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial Blagden, Sarah P

21 7 p. 969-977
artikel
                             40 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland